https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-june-1-2026/ 2026-06-02T00:25:19Z Pharminent en Rare Disease & Gene Therapy Digest • June 1, 2026 2026-06-02T00:25:14Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-1-2026/ 2026-06-01T18:00:47Z Pharminent en Strategic News Watch • June 1, 2026 2026-06-01T18:00:42Z Blog https://pharminent.com/cordenpharma-inks-ambiopharm-buyout-to-continue-peptide-production-expansion/ 2026-06-01T15:26:41Z Pharminent en CordenPharma inks AmbioPharm buyout to continue peptide production expansion 2026-06-01T14:30:25Z Blog https://pharminent.com/servier-wagers-2-65bn-on-edgewise-muscular-dystrophy-drug/ 2026-06-01T15:26:46Z Pharminent en Servier wagers $2.65bn on Edgewise muscular dystrophy drug 2026-06-01T14:26:18Z Blog https://pharminent.com/asco-summit-reached-with-china-lung-data-but-new-climb-begins-to-prove-global-benefit/ 2026-06-01T15:26:49Z Pharminent en ASCO: Summit reached with China lung data but new climb begins to prove global benefit 2026-06-01T13:35:50Z Blog https://pharminent.com/lilly-and-hanmi-sign-1-26bn-licensing-deal-for-sonefpeglutide/ 2026-06-01T15:29:49Z Pharminent en Lilly and Hanmi sign $1.26bn licensing deal for sonefpeglutide 2026-06-01T09:43:03Z Blog https://pharminent.com/fda-approves-astrazenecas-imfinzi-bcg-combination-for-nmibc-therapy-2/ 2026-06-01T15:26:53Z Pharminent en FDA approves AstraZeneca's Imfinzi-BCG combination for NMIBC therapy 2026-06-01T07:36:34Z Blog https://pharminent.com/81320-2/ 2026-06-02T00:21:00Z Pharminent en 2026-06-01T00:20:32Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-asco-2026-special-edition-mid-meeting-coverage/ 2026-05-31T20:13:39Z Pharminent en Oncology Intelligence Digest • ASCO 2026 Special Edition • Mid-Meeting Coverage 2026-05-31T19:50:53Z Blog https://pharminent.com/market-access/market-access-quarterly-deep-dive-q2-2026-pbm-exclusions/ 2026-05-31T19:23:36Z Pharminent en Market Access Quarterly Deep Dive Q2 2026 PBM Exclusions 2026-05-31T19:23:32Z Blog